Quebec physicians to re-read additional 4,500 mammos

Lisa Fratt | | Health Imaging | Diagnostic Imaging
The Quebec College of Physicians will re-read 4,500 mammograms from three clinics based on the recommendations of two medical investigators.

The expanded investigation, which began in November 2010, stems from discrepancies found in some data files during the initial investigation into quality of imaging exams at Fabreville Radiology in Laval, Quebec, and Jean-Talon Bélanger Radiology and Radiology Domus Medica clinics in Montreal.

The initial investigation into 15,000 mammograms concerned potential misreadings by one Quebec radiologist. The current review is an additional security measure and is the last stage of the investigation, the Quebec College of Physicians said in a statement.

"Currently, it is too early to conclude anything since the investigation is still open. The operation will be completed as quickly as possible and the college will release the final report as soon as possible. In total, about 22,500 films have been reviewed," said Yves Robert, MD, secretary of the Quebec College of Physicians.

All women whose studies are part of the investigation will receive a letter by mid-September, the college said.

Lisa Fratt

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.